Nav1.7抑制其引发疼痛的可能性。 - Suppr

Suppr

超能文献

Nav1.7 withholds its pain potential.

作者信息

Kingwell Katie

出版信息

Nat Rev Drug Discov. 2019 Apr 8. doi: 10.1038/d41573-019-00065-0.

DOI:10.1038/d41573-019-00065-0

PMID:31048807

Abstract

摘要

相似文献

Nav1.7 withholds its pain potential.

Nat Rev Drug Discov. 2019 Apr 8. doi: 10.1038/d41573-019-00065-0.

Discovery of (R)-(3-fluoropyrrolidin-1-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)quinolin-2-yl)methanone (ABBV-318) and analogs as small molecule Na1.7/ Nav1.8 blockers for the treatment of pain.

Bioorg Med Chem. 2022 Jun 1;63:116743. doi: 10.1016/j.bmc.2022.116743. Epub 2022 Apr 11.

Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.

Handb Exp Pharmacol. 2018;246:271-306. doi: 10.1007/164_2018_97.

Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17534-9. doi: 10.1073/pnas.1306285110. Epub 2013 Sep 30.

A Drug Discovery Approach for an Effective Pain Therapy through Selective Inhibition of Nav1.7.

Int J Mol Sci. 2022 Jun 18;23(12):6793. doi: 10.3390/ijms23126793.

Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core.

Acta Pharmacol Sin. 2020 Mar;41(3):293-302. doi: 10.1038/s41401-019-0267-z. Epub 2019 Jul 17.

Stem cell-derived sensory neurons modelling inherited erythromelalgia: normalization of excitability.

Brain. 2023 Jan 5;146(1):359-371. doi: 10.1093/brain/awac031.

Identification and Characterization of Novel Proteins from Arizona Bark Scorpion Venom That Inhibit Nav1.8, a Voltage-Gated Sodium Channel Regulator of Pain Signaling.

Toxins (Basel). 2021 Jul 18;13(7):501. doi: 10.3390/toxins13070501.

Discovery of a Novel Class of State-Dependent Na1.7 Inhibitors for the Treatment of Neuropathic Pain.

Chem Pharm Bull (Tokyo). 2020;68(7):653-663. doi: 10.1248/cpb.c20-00126.

Characterisation of Nav1.7 functional expression in rat dorsal root ganglia neurons by using an electrical field stimulation assay.

Mol Pain. 2017 Jan-Dec;13:1744806917745179. doi: 10.1177/1744806917745179. Epub 2017 Nov 22.

引用本文的文献

An unexpected insight into the cause of olfactory dysfunction: fibrillogenesis of odorant-binding proteins.

Cell Death Discov. 2025 Aug 7;11(1):370. doi: 10.1038/s41420-025-02671-x.

Sensory neuron-expressed FGF13 controls nociceptive signaling in diabetic neuropathy models.

J Clin Invest. 2025 Jul 15;135(14). doi: 10.1172/JCI183749.

CRISPR: fundamental principles and implications for anaesthesia.

Br J Anaesth. 2025 Mar;134(3):839-852. doi: 10.1016/j.bja.2024.11.040. Epub 2025 Jan 23.

The genetics of pain.

BJA Educ. 2024 Nov;24(11):417-425. doi: 10.1016/j.bjae.2024.07.004. Epub 2024 Sep 14.

Updating the Pharmacological Effects of α-Mangostin Compound and Unraveling Its Mechanism of Action: A Computational Study Review.

Drug Des Devel Ther. 2024 Oct 24;18:4723-4748. doi: 10.2147/DDDT.S478388. eCollection 2024.

Elife. 2024 Apr 30;12:RP90960. doi: 10.7554/eLife.90960.

Peripheral mechanisms of peripheral neuropathic pain.

Front Mol Neurosci. 2023 Sep 14;16:1252442. doi: 10.3389/fnmol.2023.1252442. eCollection 2023.

Development of a functional human induced pluripotent stem cell-derived nociceptor MEA system as a pain model for analgesic drug testing.

Front Cell Dev Biol. 2023 Mar 1;11:1011145. doi: 10.3389/fcell.2023.1011145. eCollection 2023.

Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels.

Front Physiol. 2023 Feb 20;14:1081186. doi: 10.3389/fphys.2023.1081186. eCollection 2023.

Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial.

Pain. 2022 Nov 1;163(Suppl 1):S15-S28. doi: 10.1097/j.pain.0000000000002675. Epub 2022 Aug 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验